Source:http://linkedlifedata.com/resource/pubmed/id/10455401
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2000-2-24
|
pubmed:abstractText |
We have systematically investigated the therapeutic potential of cationic liposome-mediated neurotrophic gene transfer for treatment of CNS injury. Following determination of optimal transfection conditions, we examined the effects of dimethylaminoethane-carbamoyl-cholesterol (DC-Chol) liposome-mediated NGF cDNA transfection in injured and uninjured primary septo-hippocampal cell cultures and rat brains. In in vitro studies, we detected an increase of NGF mRNA in cultures 1 day after transfection. Subsequent ELISA and PC12 cell biological assays confirmed that cultured cells secreted soluble active NGF into the media from day 2 after gene transfection. Further experiments showed that such NGF gene transfection reduced the loss of chol- ine acetyltransferase (ChAT) activity in cultures following calcium-dependent depolarization injury. In in vivo studies, following intraventricular injections of NGF cDNA complexed with DC-Chol liposomes, ELISA detected nine- to 12-fold increases of NGF in rat CSF. Further studies showed that liposome/NGF cDNA complexes could attenuate the loss of cholinergic neuronal immunostaining in the rat septum after traumatic brain injury (TBI). Since deficits in cholinergic neurotransmission are a major consequence of TBI, our studies demonstrate for the first time that DC-Chol liposome-mediated NGF gene transfection may have therapeutic potential for treatment of brain injury.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0969-7128
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
994-1005
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:10455401-Animals,
pubmed-meshheading:10455401-Brain Injuries,
pubmed-meshheading:10455401-Cells, Cultured,
pubmed-meshheading:10455401-Choline O-Acetyltransferase,
pubmed-meshheading:10455401-Gene Therapy,
pubmed-meshheading:10455401-Hippocampus,
pubmed-meshheading:10455401-Liposomes,
pubmed-meshheading:10455401-Nerve Growth Factors,
pubmed-meshheading:10455401-Rats,
pubmed-meshheading:10455401-Rats, Sprague-Dawley,
pubmed-meshheading:10455401-Transfection
|
pubmed:year |
1999
|
pubmed:articleTitle |
Liposome-mediated NGF gene transfection following neuronal injury: potential therapeutic applications.
|
pubmed:affiliation |
Department of Neurosurgery, Baylor College of Medicine, Houston, TX 77030, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|